2500 Participants Needed

MyPEEPS Mobile for HIV Prevention

Recruiting at 1 trial location
RS
Overseen ByRebecca Schnall, PhD, MPH
Age: < 65
Sex: Male
Trial Phase: Academic
Sponsor: Columbia University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment MyPEEPS Mobile for HIV Prevention?

The MyPEEPS Mobile app is based on an evidence-driven HIV prevention program that was originally delivered face-to-face and has been adapted for mobile use. It has been tested for usability and feasibility among young men, showing promise in reducing sexual risk behaviors.12345

How is the MyPEEPS Mobile treatment different from other HIV prevention treatments?

MyPEEPS Mobile is unique because it delivers HIV prevention information through a mobile app specifically designed for young men, making it accessible and engaging for a diverse group of young men who have sex with men. Unlike traditional face-to-face interventions, this app provides a personalized and private way to learn about HIV prevention, tailored to the needs and preferences of young users.14567

What is the purpose of this trial?

This study will use community-informed advertisements and messages through electronic methods to recruit and retain a large (N=2,500), diverse national sample of high-risk young men who have sex with men (YMSM) and non-binary individuals that are assigned male sex at birth, 16-29 years of age to determine the efficacy of the MyPEEPS Mobile intervention on reduced incident HIV infections in comparison to a standard of care condition and to examine the degree to which reduced incident HIV infections occurs in the context of potential multilevel moderators and conceptual mediators. This is key to advancing HIV prevention among HIV-negative US persons at extremely high-risk for HIV seroconversion.

Research Team

RS

Rebecca Schnall, PhD, MPH

Principal Investigator

Columbia University

RG

Robert Garofalo, MD, MPH

Principal Investigator

Ann & Robert H Lurie Children's Hospital of Chicago

DD

Dustin Duncan, ScD

Principal Investigator

Columbia University

Eligibility Criteria

The MyPEEPS LITE Trial is for young men and non-binary individuals assigned male at birth, aged 16-29, who are at high risk for HIV. Participants should be sexually active with other men and can have either a suppressed or unsuppressed HIV status.

Inclusion Criteria

Understand and read English
Live within US and its territories
Own or have access to a smartphone
See 4 more

Exclusion Criteria

I identify as transgender.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants randomized to the intervention arm will have access to MyPEEPS Mobile for 6 months, a secure web app with content delivered through games, scenarios, and role-plays within 22 mobile activities.

6 months

Control

Participants randomized to the control arm will receive standard of care, including HIV home testing every 6 months, information on sexual behaviors, and referrals for PrEP and STD testing.

6 months

Follow-up

Participants are monitored for HIV incidence and sexual risk behaviors at 6 and 12 months using OraQuick In-Home HIV Tests and the AIDS-Risk Behavior Assessment.

12 months

Treatment Details

Interventions

  • MyPEEPS Mobile
Trial Overview This trial tests the MyPEEPS Mobile intervention's effectiveness in reducing new HIV infections compared to standard care. It involves using targeted ads and messages to engage participants in prevention strategies.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants randomized to the intervention arm will have access to MyPEEPS Mobile for the next 6 months. MyPEEPS Mobile is a secure web app with content delivered through games, scenarios, and role-plays within 22 mobile activities (true/ false questions, multiple choice, matching, videos).
Group II: ControlActive Control1 Intervention
Participants randomized to the control arm will receive standard of care. This consists of HIV home testing every 6 months, information regarding sexual and other behaviors that potentiate one's risk for HIV infection, receipt of a fact sheet about PrEP and PEP, referrals to the local PrEP clinic, and referrals for local sexually transmitted disease testing.

MyPEEPS Mobile is already approved in United States for the following indications:

🇺🇸
Approved in United States as MyPEEPS Mobile for:
  • HIV prevention in young men who have sex with men (YMSM)
  • HIV prevention in young transgender men and transmasculine youth

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+

Ann & Robert H Lurie Children's Hospital of Chicago

Collaborator

Trials
275
Recruited
5,182,000+

Northwestern University

Collaborator

Trials
1,674
Recruited
989,000+

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborator

Trials
3,361
Recruited
5,516,000+

Findings from Research

The MyPEEPS Mobile intervention is a new mobile technology-based approach aimed at delivering effective HIV prevention information specifically for young men who have sex with men (YMSM).
This study represents the first test of a scaled-up version of an existing intervention, indicating a commitment to using user feedback and expert input to enhance its design and effectiveness.
Development of MyPEEPS Mobile: A Behavioral Health Intervention for Young Men.Schnall, R., Kuhns, L., Hidalgo, M., et al.[2020]
The MyPEEPS Mobile app is considered a valuable educational tool for sexual health among transmasculine youth, highlighting its potential to promote health and reduce sexual risk.
To enhance its effectiveness, the app needs adaptations that focus on personalization, inclusivity, and specific educational content tailored to the unique experiences of transmasculine youth.
A Qualitative Study to Inform Adaptation of MyPEEPS Mobile for Transmasculine Youth.Anderson, A., Karczmar, A., Kuhns, LM., et al.[2022]
A review of 24 mobile health interventions tailored for transgender and gender-expansive (TGE) youth found that many incorporate gender-affirming features and focus on HIV prevention, highlighting the importance of these technologies in addressing health disparities.
While many interventions show promise in providing medical and psychological gender affirmation, most have not undergone rigorous evaluation through randomized controlled trials, indicating a need for more evidence-based approaches in TGE-responsive mHealth.
mHealth for transgender and gender-expansive youth: harnessing gender-affirmative cross-disciplinary innovations to advance HIV prevention and care interventions.Skeen, SJ., Cain, D., Gamarel, KE., et al.[2023]

References

Development of MyPEEPS Mobile: A Behavioral Health Intervention for Young Men. [2020]
A Qualitative Study to Inform Adaptation of MyPEEPS Mobile for Transmasculine Youth. [2022]
mHealth for transgender and gender-expansive youth: harnessing gender-affirmative cross-disciplinary innovations to advance HIV prevention and care interventions. [2023]
Pilot feasibility trial of the MyPEEPS mobile app to reduce sexual risk among young men in 4 cities. [2022]
A Mobile Health Intervention for HIV Prevention Among Racially and Ethnically Diverse Young Men: Usability Evaluation. [2022]
A Mobile Sexual Health App on Empowerment, Education, and Prevention for Young Adult Men (MyPEEPS Mobile): Acceptability and Usability Evaluation. [2020]
Adaptation of a Group-Based HIV RISK Reduction Intervention to a Mobile App for Young Sexual Minority Men. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security